Gastroenterology
Ulcerative Colitis
Crohn’s Disease
C. Diff
Previous trials in this therapeutic area:
Abbvie: Phase 3; Drug- Risankizumab vs. Ustekinumab; Crohn's Disease
Arena Pharmaceuticals (Pfizer): Phase 3; Drug- Etrasimod; Crohn’s Disease
Astrazeneca: Phase 2 EXTENSION; Drug- Brazikumab; Ulcerative Colitis
Bausch Health Americas: Phase 2; Drug- MT-1303; Ulcerative Colitis
Janssen Research & Development: Phase-1; Drug- Guselkumab; Celiac Disease
Protagonist Therapeutics, Inc: Phase 2; Drug- PN-943; Ulcerative Colitis
Ventyx Biosciences, Inc: Phase 2; Drug- VTX002; Ulcerative Colitis
Ventyx Biosciences, Inc: Phase 2; Drug- VTX958; Crohn’s Disease